About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Can Coronary Artery Disease Be Eliminated In Our Lifetime?
By
Complex Coronary Valvular and Vascular Cases Conference
November 14, 2017
2 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
26th Annual San Diego Heart Failure Symposium
26th Annual San Diego Heart Failure Symposium
Sat, Sep 26, 2020
Cardiometabolic Health Congress (CMHC)
15th Annual Cardiometabolic Health Congress
Wed, Oct 21, 2020
The American Society for Preventive Cardiology
Virtual Summit on Cardiovascular Disease Prevention
Sat, Jul 25, 2020
16:57
William White
Ambulatory Blood Pressure Monitoring
12:04
Stephen Kopecky
Role of PCSK9 Inhibitors in Diabetes
11:10
Craig Beavers
PCSK9 Inhibitors: Pharmacology, Indications, Drug Interactions, Dosing L...
21:10
National Lipid Association
Plant-based Diets for Improving Lipids
Feat.
K. Williams
14:42
American Society of Nuclear Cardiology
Evaluation of 63-Year-Old Intermediate Risk Female with Chest Pain
Feat.
D. Wolinsky
16:12
ASPC 2018 Congress on CVD Prevention
Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Hi...
Feat.
P. Moriarty
25:41
National Lipid Association
Cardiodiabetology: Optimizing ASCVD Risk Reduction
Feat.
N. Wong
38:27
ASPC 2018 Congress on CVD Prevention
Gaining Access to PCSK9 Inhibitors: Dissemination of a Mobile App and Mo...
Feat.
S. Baum
16:19
Cardiometabolic Health Congress (CMHC)
Navigating the Web of the Prescription Approval and Appeals Process: A C...
27:02
ASPC 2019 Congress on CVD Prevention
Expanded use of CAC testing in 2018 Cholesterol Guidelines- How to Apply?
Feat.
R. Blankstein
10:49
Northwestern Medicine Cardiovascular Care
Clyde W. Yancy, MD and Neil J. Stone, MD Discuss New Cardiovascular Guid...
Feat.
C. Yancy,
N. Stone
13:55
ASPC 2019 Congress on CVD Prevention
2019 Prevention Guidelines: Applying the Guidelines to Practice
Feat.
S. Virani
12:11
Peter Howard Jones
Clinical Trials with PCSK9 Inhibitors and Lipid Efficacy
45:19
ASPC 2019 Congress on CVD Prevention
REDUCE-IT and Treating Beyond LDL-C Lowering
Feat.
D. Bhatt
25:22
Cardiometabolic Health Congress (CMHC)
Non-Statin Drugs and New Approaches
Feat.
M. Sabatine,
C. Ballantyne
32:14
ASPC 2019 Congress on CVD Prevention
Unraveling the Mysteries of Heart Disease: Lessons from the 70 Year Lega...
Feat.
D. Levy
17:40
Cardiovascular Disease Management - 4th Annual Symposium
Can We Cure Arteriosclerosis? New Thoughts and Concepts and New Game Cha...
20:26
25th Annual San Diego Heart Failure Symposium
What’s New in Treating Hyperlipidemia: Update on PCSK9 Inhibition and Tr...
Feat.
P. Taub
28:16
American Society of Nuclear Cardiology
Women with Suspected Ischemic Heart Disease: What is the Best Diagnostic...
Feat.
J. Mieres
14:35
ASPC 2019 Congress on CVD Prevention
Newer Insights Into Why the SGLT2s Reduce Heart Failure in Patients With...
Feat.
R. Chilton
